FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/30/2022
Back to search
Official data from USPTO
TRUMDACIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
09/02/2022
Trademark type
Word
Nice classes
5
Filing date
09/22/2020
Registration date
11/16/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/16/2021
Last transaction
09/02/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
CN
Examiner
BELLOTTI, CHRISTINA L
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Hangzhou DAC Biotech Co., Ltd.
Representatives
Zhi Dong Hamre, Schumann, Mueller & Larson, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for use in oncology; anticancer agent in the nature of anti-cancer preparations; medical reagent in the nature of reagents for medical use; drugs for cancer in the nature of biological preparations for the treatment of cancer
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/07/2022
FIMP
FINAL DISPOSITION PROCESSED
05/06/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/16/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/16/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/31/2021
PUBO
PUBLISHED FOR OPPOSITION
08/31/2021
GPNX
NOTIFICATION PROCESSED BY IB
08/29/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/11/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/11/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/11/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/23/2021
DOCK
ASSIGNED TO EXAMINER
06/28/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/08/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/07/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/07/2021
RFNT
REFUSAL PROCESSED BY IB
03/15/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/25/2021
RFRR
REFUSAL PROCESSED BY MPU
02/25/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/17/2021
CNRT
NON-FINAL ACTION WRITTEN
02/16/2021
DOCK
ASSIGNED TO EXAMINER
02/09/2021
MAFR
APPLICATION FILING RECEIPT MAILED
12/18/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/14/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/10/2020
Continuous trademark protection
Get notified about every new filing that threatens TRUMDACIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.